home technology applications about us news
deltaDOT is a spin out company from Imperial College London UK - a team of scientists and  engineers dedicated to the advancement of analytical techniques using patented methods and  instrumentation in High Performance Capillary Electrophoresis (HPCE). We design and  produce HPCE instruments which we are marketing worldwide. We also use the same  instruments to offer Analytical Services and Contract Research. Our offices and laboratories  are based in the London Bioscience Innovation Centre (LBIC). 
Who we are 
HPCE instruments 
High Performance Capillary Electrophoresis (HPCE) analytical instruments are designed,  manufactured and marketed by deltaDOT. These instruments use deltaDOT’s proprietary  imaging and analysis technology called Label Free Intrinsic Imaging (LFII®). High  Performance Capillary Electrophoresis and Label Free Intrinsic Imaging applied to a CE  analytical system  offers dramatically improved discovery power in comparison to other  conventional CE systems.
deltaDOT team of scientists has developed considerable expertise in CE based analysis and in  solving clients’ analytical problems. Using our own HPCE LFII® analytical instruments we also  offer Analytical Services and Contract Research to industry and academia from our  laboratories in the London Bioscience Innovation Centre.  
Analytical Services & Contract Research 
HPCE Applications 
High Performance Capillary Electrophoresis (HPCE) is applied in Life Sciences research, drug  testing, diagnostics and bio-pharmaceutical manufacturing. This technology is used in  detection, separation and analysis of proteins, nucleic acids, carbohydrates, viruses and  bacteria, chemicals and a wide range of other analytes. More detail can be found on our  Technology pages. 
Application Notes Downloads Quick Update 
Antibody Analysis, Amino Acid Analysis, Transferrin, Small Molecules, Peptides, Complex  Protein Lysates, Recombinant Human Erythropoietin, Antibiotics in food products, Glycoforms,  DNA, RNA, Chemicals, Baculovirus Titre.  Glomerular filtration rate (GFR) determined by Iohexol clearance was developed in  collaboration with Royal Veterinary College for renal failure diagnosis in companion animals  (...more) 
26th January 2016, National Health Service Quality Control North West (QCNW)  Liverpool Labs are to perform monoclonal antibody stability trials, utilising deltaDOT Ltd  technology and expertise to aid the study (...more)  4th February 2016 Webinair: Improve your Monoclonal Antibodies Analysis. Live  webinair on analysing mAbs from production to patient. Given jointly by Horiba Scientific  and deltaDOT Ltd. Presented by Dr. Deepika Devanur (...go to registration site)  14th December 2015, deltaDOT technology used to define product quality for  ImmBio Ltd. deltaDOT Ltd (London) are pleased to announce that its Label Free  Intrinsic Imaging (LFII®) technology has been used to help ImmBio (Cambridge UK) to  submit an Investigational Medicinal Product Dossier (IMPD) as part of a clinical trial  application to The Medicines and Healthcare products Regulatory AgencMHRA (...more)  24th  November 2015, NW Labs are to market a kidney function test developed by  deltaDOT Ltd and the Royal Veterinary College. At the London Vet Show held at  Olympia on 19 and 20 Nov 2015 it was announced that NW Labs are now promoting  deltaDOT’s Glomerular filtration rate (GFR) assay for measuring kidney function in cats  and dogs. NW Labs will refer cases of suspected early stage renal disease for  measurement by deltaDOT with interpretation and advice on management by expert  clinicians at the Royal Veterinary College, London (...more)  12-14 March 2015, 2nd International Conference on Label-Free Technologies  Boston Marriott Cambridge, MA, USA. Dr. Stuart Hassard will be speaking on Label free  intrinsic imaging high performance capillary electrophoresis - a powerful tool in  analytical science. 4th, 5th March 2015 Keeping pace - Analytics for tomorrow’s biopharmaceuticals    conference, Leeds, UK. Dr. Stuart Hassard will be speaking on Label free intrinsic  imaging high performance capillary electrophoresis trends throughout biopharmaceutical process analytical technology. 21st October 2014 deltaDOT CSO Dr. Stuart Hassard to co-Chair BBSRC  Strategic  Tools and Resources Development Fund committee in November (...more). 18 October 2014 deltaDOT’s Label-free HPCE-512 - a key instrument in accurate  analysis of drug-antibody complexes (DAR); see a recent Paper “Next generation  maleimides enable the controlled assembly of antibody–drug conjugates via native  disulfide bond bridging” (...more). 12 August 2014 deltaDOT and the Royal Veterinary College partnership have  launched a new therapeutic drug monitoring service. The service offered is a measure of  glomerular filtration rate (GFR) in companion animals, widely considered to be the gold  standard test for kidney function (more...)  18 December 2013 deltaDOT chosen as supplier to National Center for Therapeutics  Manufacturing, College Station, Texas. London, UK, - deltaDOT Ltd announced the  sale of their HPCE-512 instruments to the Texas A&M Center for Innovation in Advanced  Development and Manufacturing (CIADM).  The implementation of the HPCE-512  technology at the CIADM will facilitate the establishment of enhanced analytical  capabilities in the Center’s facilities ...more